July 18, 2025 07:00 AM EDT

Bill Anderson to stay on at Bayer; C-suite changes at troubled Sarepta

Kathy Wong

Editor

Lots to recap this week for Peer Review!

→ Bayer CEO Bill Anderson has been given at least three more years at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Summit plans to take lung cancer drug to FDA, plots combo use and study changes

Anthropic debuts first AI product for life sciences as it builds out bio team

FDA staffing data show historic numbers of departures in fiscal 2025

RAPT, Jeyou are itching to start Phase 3 after encouraging mid-stage results in urticaria

Three blockbusters prompt CBO to raise orphan drug expansion cost estimate to $8.8B over 10 years

sponsored

The advent of digital therapeutics and what it means for healthcare